Intelligent Bio Solutions... (INBS)
2.10
-0.06 (-2.78%)
At close: Mar 24, 2025, 3:59 PM
2.14
1.75%
After-hours: Mar 24, 2025, 07:58 PM EDT
-2.78% (1D)
| Bid | 2.08 |
| Market Cap | 14.25M |
| Revenue (ttm) | 4.53M |
| Net Income (ttm) | -15.98M |
| EPS (ttm) | 0.12 |
| PE Ratio (ttm) | 17.5 |
| Forward PE | 4.11 |
| Analyst | n/a |
| Ask | 2.19 |
| Volume | 72,384 |
| Avg. Volume (20D) | 206,098 |
| Open | 2.14 |
| Previous Close | 2.16 |
| Day's Range | 1.98 - 2.17 |
| 52-Week Range | 1.00 - 4.64 |
| Beta | 4.64 |
About INBS
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a b...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Dec 23, 2020
Employees 50
Stock Exchange NASDAQ
Ticker Symbol INBS
Website https://gbs.inc
1 month ago
-20.45%
Intelligent Bio Solutions shares are trading lower...
Unlock content with
Pro Subscription
1 month ago
+19.71%
Intelligent Bio Solutions shares are trading higher. The stock may be moving on continued strength after the company released on Monday a shareholder letter highlighting its growth for 2024 and strategy for 2025.
